News

object(WP_Post)#1122 (24) { ["ID"]=> int(460) ["post_author"]=> string(1) "1" ["post_date"]=> string(19) "2019-09-09 18:59:15" ["post_date_gmt"]=> string(19) "2019-09-09 18:59:15" ["post_content"]=> string(2608) "[caption id="attachment_451" align="alignleft" width="346"]Nabil Al-Tawil, Principal Consultant of BIO1  Nabil Al-Tawil, Principal Consultant of BIO1[/caption] September 2019 – BIO1 early phase clinical trials unit announced the appointment of Nabil Al-Tawil to the role of Principal Consultant. Nabil will play an important role in supporting clinical studies conducted at BIO1. He will guide, advise and provide thorough consultations from study design development to study execution. „Nabil brings a great combination of medical knowledge and expertise in clinical trial planning and management. He has a proven track record in leading more than 70 clinical trials. Nabil Al-Tawil is a well-esteemed medical professional, who will provide great support in achieving outstanding deliverables to BIO1 work.“ said Justinas Ivaška, MD, PhD, BIO1 General Manager. Nabil Al-Tawil graduated from the College of Medicine, University of Baghdad, qualified as a Medical Doctor. As well, Nabil holds a master's degree in the field of science, and a PhD degree from the Karolinska Institutet, specializing in clinical immunology. He was a professor and a member of the editorial board of the Journal of the Faculty of Medicine and was also a member of many national committees (AIDS, vaccines, polio eradication, etc.) in the Ministry of Health. Nabil has more than four decades of experience working in the field of clinical research. Before joining BIO1, Nabil worked as a consultant physician at the KTA Phase I unit at the Karolinska University Hospital. Since 2006, Nabil Al-Tawil led more than 70 clinical trials, including first-in-human studies.

About BIO1 Clinical Trial Unit

BIO1 provides facilities and expertise to investigate novel medicines and medical devices. We occupy a large clinical space of 500 m2 plus an administrative area of 120 m2 – all of which is modern, immaculate and has the very latest equipment. Combining the knowledge with the best doctors in the region, we ensure the highest standards in early phase clinical trials." ["post_title"]=> string(44) "

BIO1 appoints Principal Consultant

" ["post_excerpt"]=> string(138) "September 2019 – BIO1 early phase clinical trials unit announced the appointment of Nabil Al-Tawil to the role of Principal Consultant." ["post_status"]=> string(7) "publish" ["comment_status"]=> string(4) "open" ["ping_status"]=> string(4) "open" ["post_password"]=> string(0) "" ["post_name"]=> string(25) "bio1-principal-consultant" ["to_ping"]=> string(0) "" ["pinged"]=> string(0) "" ["post_modified"]=> string(19) "2019-09-23 08:11:52" ["post_modified_gmt"]=> string(19) "2019-09-23 08:11:52" ["post_content_filtered"]=> string(0) "" ["post_parent"]=> int(0) ["guid"]=> string(28) "https://bio1trials.com/?p=460" ["menu_order"]=> int(0) ["post_type"]=> string(4) "post" ["post_mime_type"]=> string(0) "" ["comment_count"]=> string(1) "0" ["filter"]=> string(3) "raw" }

object(WP_Post)#1037 (24) { ["ID"]=> int(379) ["post_author"]=> string(1) "1" ["post_date"]=> string(19) "2019-09-05 07:21:49" ["post_date_gmt"]=> string(19) "2019-09-05 07:21:49" ["post_content"]=> string(3141) "[caption id="attachment_380" align="alignleft" width="498"]Justinas Ivaška, General Manager of BIO1                             Justinas Ivaška, General Manager of BIO1[/caption] September 2019 – Pioneering Phase I unit in the Baltic States, BIO1, officially announced the appointment of Justinas Ivaška to the role of General Manager. Located in the leading university hospital in Lithuania from primary care to tertiary level - Vilnius University Hospital, Santaros Klinikos, BIO1 creates an outstanding space to reach added value in clinical trials. As the first early phase unit in the region, BIO1 is dedicated to ensuring the highest standards when working with healthy volunteers and patients. Justinas Ivaška will play an important role in the provision of early phase unit services, ensuring highest quality standards and maximizing the efficiency of clinical conduct. Justinas will be responsible for daily operations and will work on the implementation of the overall company business development strategy. „Justinas combines the in-depth medicinal knowledge with experience of business development and management. His professional background reveals that Justinas is a decisive strategic and analytical leader, what’s make him exceptionally well suited to lead BIO1 improvement. Justinas undoubtedly will be a highly valued addition to BIO1 team.“ said Eglė Pavydė, BIO1 Director Business Development. Justinas Ivaška graduated from Vilnius University, Faculty of Medicine, qualified as Medical Doctor. As well, Justinas holds a Bachelor degree in Business administration and Management and a PhD degree in Biomedical Sciences. Since 2017, Justinas is an Associate professor of the Faculty of Medicine at Vilnius University. Justinas Ivaška has more than 21 years of experience working as a medical doctor, specializing in otorhinolaryngology. Before joining BIO1, Justinas was working as Director of Business Development at Vilnius University Hospital, Santaros Klinikos. He was responsible for project management, the establishment of new health care departments, medical systems and implementation of therapeutic technologies.

About BIO1 Clinical Trial Unit

BIO1 provides facilities and expertise to investigate novel medicines and medical devices. We occupy a large clinical space of 500 m2 plus an administrative area of 120 m2 – all of which is modern, immaculate and has the very latest equipment. Combining the knowledge with the best doctors in the region, we ensure the highest standards in early phase clinical trials." ["post_title"]=> string(39) "

BIO1 appoints General Manager

" ["post_excerpt"]=> string(159) "September 2019 – Pioneering Phase I unit in the Baltic States, BIO1, officially announced the appointment of Justinas Ivaška to the role of General Manager." ["post_status"]=> string(7) "publish" ["comment_status"]=> string(4) "open" ["ping_status"]=> string(4) "open" ["post_password"]=> string(0) "" ["post_name"]=> string(29) "bio1-appoints-general-manager" ["to_ping"]=> string(0) "" ["pinged"]=> string(0) "" ["post_modified"]=> string(19) "2019-09-09 18:53:24" ["post_modified_gmt"]=> string(19) "2019-09-09 18:53:24" ["post_content_filtered"]=> string(0) "" ["post_parent"]=> int(0) ["guid"]=> string(28) "https://bio1trials.com/?p=379" ["menu_order"]=> int(0) ["post_type"]=> string(4) "post" ["post_mime_type"]=> string(0) "" ["comment_count"]=> string(1) "0" ["filter"]=> string(3) "raw" }